HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic value of Angiographic Perfusion Score (APS) following percutaneous interventions in acute coronary syndromes.

AbstractINTRODUCTION:
Identifying reperfusion and predicting post procedure risk is important following Percutaneous Coronary Interventions (PCI). An Angiographic Perfusion Score (APS) combining TIMI flow (TFG) and myocardial perfusion (TMPG) grades before and after PCI can accurately measure both epicardial and myocardial perfusion and predict Major Adverse Cardiac Events (MACE).
PATIENTS AND METHODS:
APS was calculated in 226 (88 ST elevation Myocardial Infarction (STEMI) and 138 Non STEMI) patients. Maximum score being 12, reperfusion was defined as failed: 0-3, partial: 4-9, and full APS: 10-12. Thirty day MACE were observed.
RESULTS:
APS identified reperfusion significantly more than TMPG alone (STEMI: 50.6% vs 11.8% (p < 0.001); Non STEMI, early reperfusion: 69.4% vs 52.8% (p < 0.01) and Non STEMI late reperfusion: 38.2% vs 7.8%; (p ≤ 0.001) respectively. A significantly lower incidence of MACE was observed in the full as compared to the failed APS group (1.8% vs 22.5%) (p < 0.001). No differences were noted between TMPG 0-2 (9.8%, 9.4%, 7.3%, respectively) (p = NS).
CONCLUSION:
Compared to MPG alone APS detects more low risk reperfused patients, post PCI.
AuthorsV S Narain, L Fischer, A Puri, R Sethi, S K Dwivedi
JournalIndian heart journal (Indian Heart J) 2013 Jan-Feb Vol. 65 Issue 1 Pg. 1-6 ISSN: 0019-4832 [Print] India
PMID23438605 (Publication Type: Journal Article)
CopyrightCopyright © 2012. Published by Elsevier B.V.
Topics
  • Acute Coronary Syndrome (diagnostic imaging, therapy)
  • Chi-Square Distribution
  • Coronary Angiography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Reperfusion (methods)
  • Percutaneous Coronary Intervention
  • Predictive Value of Tests
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: